Amgen to Acquire Alantos
Amgen has another merger in process, now with Alantos for $300 million.
RED HERRING | Amgen to Acquire Alantos:
Now they also are purchasing Ilpysa which I posted about recently. Altantos has a phase II drug for diabetes a somewhat crowded market. I personally think they may have overpiad for what they get.
I find it interesting that now even the biotechs are getting into the acquisition mania. It wouldn’t surprise me if Genetech starts on a buying binge just to keep pace.
Technorati Tags: Amgen, Ilypsa, Alantos
Related Posts:
Bookmark it with:
| 
del.icio.us
| 
Digg it
| 
Furl
| 
Simpy
| 
Spurl
| 
My Yahoo!
|
